Angioedema Treatment Market Set for Strong Growth, Projected to Reach USD 30.3 Billion by 2035

The global Angioedema Treatment Market is poised for substantial growth, with the market estimated to reach USD 6.5 billion in 2025 and projected to surge to USD 30.3 billion by 2035, reflecting a compound annual growth rate (CAGR) of 16.6% over the forecast period. This robust growth is driven by rising awareness, advancements in drug development, and increasing healthcare investments aimed at improving patient outcomes for those suffering from this potentially life-threatening condition.

Unlock detailed analytics - Request your personalized report now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1712

Key Market Drivers

Several factors are contributing to the escalating demand for angioedema treatment solutions. Primarily, the rising prevalence of both hereditary and acquired angioedema is fueling the market. Increased recognition of the condition by healthcare providers, alongside better diagnostic tools and treatment options, has further heightened the market's expansion. Patients now have access to more rapid and effective interventions, reducing the severity of episodes and improving overall quality of life.

Angioedema, characterized by swelling beneath the skin's surface, often affects areas such as the hands, feet, lips, and eyes. The condition can arise from allergies, genetic predisposition, or certain medications. While treatment cannot always fully cure the condition, the development of targeted therapies and medications has enhanced symptom management, reducing hospitalizations and emergency care visits.

Leading Drug Classes and Therapeutic Solutions

The antihistamines segment is expected to maintain its dominant position, accounting for 33.2% of the market share in 2025. Antihistamines are widely utilized due to their effectiveness in managing histamine-induced angioedema, particularly in cases of allergic reactions and idiopathic angioedema. Their rapid onset of action and favorable safety profile make them a preferred option in emergency situations.

Corticosteroids and biologics are also gaining prominence in the market, especially for patients experiencing more severe or chronic forms of angioedema. Biologics, in particular, are a growing area of interest due to their precision in targeting specific immune pathways involved in angioedema development.

Hospital-Based Treatments Lead the Market

Hospitals are expected to be the primary end-use segment, accounting for 52.3% of the market share in 2025. Emergency room visits for acute angioedema episodes often require immediate medical intervention, making hospitals critical for managing severe cases. Hospitals not only provide the necessary resources for rapid treatment, including intravenous therapies, but also serve as central hubs for clinical trials and specialized patient care.

As healthcare systems worldwide continue to invest in infrastructure, particularly in emerging economies, hospital-based treatment capabilities are expanding, further solidifying the hospital segment's market dominance.

Regional Insights and Market Dynamics

North America is anticipated to remain the leading region in the angioedema treatment market, driven by high awareness and prevalence rates. The USA alone is expected to represent a significant portion of the market, with sales projected to grow from USD 2.5 billion in 2025 to USD 9.2 billion by 2035. The European market is also poised for steady growth, led by countries like Germany, which is forecasted to grow at a CAGR of 19.1%.

Asia-Pacific regions, particularly China and India, are showing the highest growth potential. China's angioedema treatment market is projected to grow at a remarkable CAGR of 22.4%, while India follows closely with a 20.8% growth rate. This growth is attributed to increasing awareness, better healthcare access, and rising incidences of allergies.

While Brazil lags with the lowest growth rate (12.5%), the market still underscores positive momentum, indicating an overall global expansion for angioedema treatments.

Competitive Landscape

The Angioedema Treatment Market is highly competitive, with several established pharmaceutical companies leading the charge in developing innovative treatments. Shire plc., CSL Limited, Pharming Group NV, and Ionis Pharmaceuticals, Inc. are among the top players investing heavily in research and development to bring new therapies to market. These companies are focused on expanding their product portfolios and refining treatments, including the development of biologic therapies that target specific molecular mechanisms of the condition.

The CRISPR genome-editing technology has emerged as a cutting-edge solution for patients with hereditary angioedema, providing hope for reducing the frequency and severity of attacks. This innovation is expected to drive the next phase of growth in the market, as the medical community looks for more precise, long-term solutions for managing the condition.

Challenges and Market Restraints

Despite the promising growth trajectory, the angioedema treatment market faces challenges, particularly in developing regions where awareness and diagnostic resources are limited. Additionally, the cost of advanced treatments like biologics may hinder market penetration in low-income and middle-income countries. Furthermore, while progress is being made, there remains a need for more targeted, long-term cures for hereditary and drug-induced forms of angioedema.

Get Full Access of this Report:
https://www.futuremarketinsights.com/reports/angioedema-treatment-market

Explore Related Research Reports on Healthcare Domain

Nasopharyngeal Carcinoma Treatment Market:
https://www.futuremarketinsights.com/reports/nasopharyngeal-carcinoma-treatment-market

Ventricular Fibrillation Treatment Market:
https://www.futuremarketinsights.com/reports/ventricular-fibrillation-treatment-market

Spasticity Treatment Market:
https://www.futuremarketinsights.com/reports/spasticity-treatment-market

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.